A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

Antibodies, also known as immunoglobulins, are specialized proteins produced by the immune system to identify and neutralize foreign invaders, such as viruses, bacteria, and other pathogens. They are ...

Lifordi Immunotherapeutics and other biotechnology companies are using antibodies to precisely target drugs in the body.

In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease. Experts from the University of ...

An antibody (teal) bound to its target, the HIV protein Env (white and gray), also attaches to an immune cell via a receptor (red) on the immune cell’s surface. This interaction can activate the ...

Researchers at Texas Biologics at The University of Texas at Austin recently made a discovery that they believe could ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

Researchers at Sanford Burnham Prebys and scientists from Eli Lilly and Co., have revealed the structure and function of a drug called LY3361237, which can reduce the harmful activity of the immune ...

MOG antibody-associated disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients ...